TY  - GEN 
AU  - Berenguer, Juan
AU  - González, Juan
AU  - Rivera, Esteban
AU  - Domingo, Pere
PY  - 2008
UR  - https://hdl.handle.net/10481/91013
AB  - Background: The combination of didanosine, lamivudine, and efavirenz (ddI/3TC/EFV) for the initial treatment of human immunodeficiency virus type 1 (HIV-1) infection has been insufficiently analyzed in clinical trials.

Methods: We conducted an...
LA  - eng
TI  - Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903
DO  - 10.1086/592114
ER  -